Mutations in the Wilms' tumor gene WT1 in leukemias

Blood

Volumn 87, Issue 6, 1996, Pages 2171-2179

  King Underwood, L ^a   Renshaw, J ^a   Pritchard Jones, K ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CHILD; EXON; GENE MUTATION; HUMAN; HUMAN TISSUE; NEPHROBLASTOMA; NONSENSE MUTATION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

ACUTE DISEASE; ADOLESCENT; ADULT; AMINO ACID SEQUENCE; BASE SEQUENCE; CELLS, CULTURED; CHILD; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; DNA-BINDING PROTEINS; EXONS; FATAL OUTCOME; FEMALE; GENES, WILMS TUMOR; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA; MALE; MOLECULAR SEQUENCE DATA; MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROGNOSIS; RNA, NEOPLASM; TRANSCRIPTION FACTORS; WT1 PROTEINS; ZINC FINGERS;

EID: 0029921478     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.6.2171.bloodjournal8762171     Document Type: Article

References (53)

1. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C, Housman DE. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60:509, 1990
2. Gessler M, Poustka A, Cavence W, Neve RL, Orkin SH, Bruns GA. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 343:774, 1990
3. Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE: Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci USA 88:9618, 1991
4. Brenner B, Wildhardt G, Schneider S, Royer-Pokora B: RNA polymerase chain reaction detects different levels of four alternatively spliced WT1 transcripts in Wilms' tumors. Oncogene 7:1431, 1992
5. Sharma PM, Bowman M, Madden SL, Rauscher Fr, Sukumar S: RNA editing in the Wilms' tumor susceptibility gene, WT1. Genes Dev 8:720, 1994
6. Wang ZY, Qui QQ, Enger KT, Deuel TF: A second transcriptionally active DNA-binding site for the Wilms tumor gene product. WT1. Proc Natl Acad Sci USA 90:8896, 1993
7. Drummond IA, Rupprecht HD, Rohwer-Nutter P, Lopez-Guisa JM, Madden SL, Rauscher FR, Sukhatme VP: DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1. Mol Cell Biol 14:3800, 1994
8. Larsson SH, Charlieu JP, Miyagawa K, Engelkamp D, Rassoulzadegan M, Ross A, Cuzin F, van-Heyningen V, Hastie ND: Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell 81:391, 1995
9. Wang ZY, Qiu QQ, Huang J, Gurrieri M, Deuel TF: Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways. Oncogene 10:415, 1995
10. Wang ZY, Madden SL, Deuel TF, Rauscher FJ: The Wilms' tumor gene product. WT1, represses transcription of the platelet-derived growth factor A-chain gene. J Biol Chem 267:21999, 1992
11. Harrington MA, Konicek B, Song A, Xia XL, Fredericks WJ, Rauscher FJ: Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus. J Biol Chem 268:21271, 1993
12. Drummond IA, Madden SL, Rohwer-Nutter P, Bell GI, Sukhatme VP, Rauscher FJ: Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science 257:674, 1992
13. Rupprecht HD, Drummond IA, Madden SL, Rauscher FJ, Sukhatme VP: The Wilms' tumor suppressor gene WT1 is negatively autoregulated. J Biol Chem 269:6198, 1994
14. Gessler M, Konig A, Arden K, Grundy P, Orkin S, Sallan S, Peters C, Ruyle S, Mandell J, Li F, Cavenee W, Bruns G: Infrequent mutation of the WT1 gene in 77 Wilms' tumors. Hum Mutat 3:212, 1994
15. Brown KW, Wilmore HP, Watson JE, Mott MG, Berry PJ, Maitland NJ: Low frequency of mutations in the WT1 coding region in Wilms' tumor. Genes Chromosom Cancer 8:74, 1993
16. Varanasi R, Bardeesy N, Ghahremani M, Petruzzi MJ, Nowak N, Adam MA, Grundy P, Shows TB, Pelletier J: Fine structure analysis of the WT1 gene in sporadic Wilms tumors. Proc Natl Acad Sci USA 91:3554, 1994
17. Little MH, Prosser J, Condie A, Smith PJ, Van-Heyningen V, Hastie ND: Zinc finger point mutations within the WT1 gene in Wilms tumor patients. Proc Natl Acad Sci USA 89:4791, 1992
18. Knudson A J, Strong LC: Mutation and cancer: A model for Wilms' tumor of the kidney. J Natl Cancer Inst 48:313, 1972
19. Hastie ND: Wilms' tumour gene and function. Curr Opin Genet Dev 3:408, 1993
20. Park S, Schalling M, Bernard A, Maheswaran S, Shipley GC, Roberts D, Fletcher J, Shipman R, Rheinwald J, Demetri G, Griffin J, Minden M, Housman D, Haber DA: The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma. Nat Genet 4:415, 1993
21. Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, Fine R, Silverman BL, Haber DA, Housman D: Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67:437, 1991
22. Miyagi T, Ahuja H, Kubota T, Kubonishi I, Koeffler HP, Miyoshi I. Expression of the candidate Wilm's tumor gene, WT1, in human leukemia cells. Leukemia 7:970, 1993
23. Brieger J, Weidmann E, Fenchel K, Mitrou PS, Hoelzer D, Bergmann L: The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells. Leukemia 8:2138, 1994
24. Miwa H, Beran M, Saunders GF: Expression of the Wilms' tumor gene (WT1) in human leukemias. Leukemia 6:405, 1992
25. Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H, Kita K, Hiraoka A, Masaoka T, Nasu K, Kyo T, Dohy H, Nakauchi H, Ishidate T, Akiyama T, Kishimoto T: WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 84:3071, 1994
26. Moss TJ, Strauss LC, Das L, Feig SA: Secondary leukemia following successful treatment of Wilms' tumor. Am J Pediatr Hematol Oncol 11:158, 1989
27. Hartley AL, Birch JM, Harris M, Blair V, Morris-Jones PH, Gattamaneni HR, Kelsey AM: Leukemia, lymphoma, and related disorders in families of children diagnosed with Wilms' tumor. Cancer Genet Cytogenet 77:129, 1994
28. Pritchard-Jones K, Renshaw J, King-Underwood L: The Wilms tumour (WT1) gene is mutated in a secondary leukaemia in a WAGR patient. Hum Mol Genet 3:1633, 1994
29. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215, 1988
30. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
31. Wilkinson M: RNA isolation: A mini-prep method. Nucleic Acids Res 16 10933, 1988
32. Little MH, Williamson KA, Mannens M, Kelsey A, Gosden C, Hastie ND, van-Heyningen V: Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion. Hum Mol Genet 2:259, 1993
33. Baird PN, Groves N, Haber DA, Housman DE, Cowell JK: Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndrome. Oncogene 7:2141, 1992
34. Winship PR: An improved method for directly sequencing PCR amplified material using dimethyl sulphoxide. Nucleic Acids Res 17:1266, 1989
35. Brown KW, Watson JE, Poirier V, Mott MG, Berry PJ, Maitland NJ: Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient. Oncogene 7:763, 1992
36. Horikoshi T, Danenberg KD, Stadlbauer THW, Volkenandt M, Shea LCC, Aigner K, Gustavsson B, Leichman L, Frosing R, Ray M, Gibson NW, Spears CP, Danenberg PV: Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction Cancer Res 52:108, 1992
37. Langerak AW, Williamson KA, Miyagawa K, Hagemeijer A, Versnel MA, Hastie ND: Expression of the Wilms' tumor gene WT1 in human malignant mesothelioma cell lines and relationship to platelet-derived growth factor A and insulin-like growth factor 2 expression. Genes Chromosom Cancer 12:87, 1995
38. Groves N, Baird PN, Hogg A, Cowell JK: A single base pair polymorphism in the WT1 gene detected by single-strand conformation polymorphism analysis. Hum Genet 90:440, 1992
39. Tadokoro K, Oki N, Sakai A, Fujii H, Ohshima A, Nagafuchi S, Inoue T, Yamada M: PCR detection of 9 polymorphisms in the WT1 gene. Hum Mol Genet 2:2205, 1993
40. Hamilton TB, Barilla KC, Romaniuk PJ: High affinity binding sites for the Wilms' tumour suppressor protein WT1. Nucleic Acids Res 23:277, 1995
41. Bickmore WA, Oghene K, Little MH, Seawright A, van-Heyningen V, Hastie ND: Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript. Science 257:235, 1992
42. Ryan G, Steele-Perkins V, Morris JF, Rauscher FR, Dressler GR: Repression of Pax-2 by WT1 during normal kidney development. Development 121:867, 1995
43. Goodyer P, Dehbi M, Torban E, Bruening W, Pelletier J: Repression of the retinoic acid receptor-alpha gene by the Wilms' tumor suppressor gene product, wt1. Oncogene 10:1125, 1995
44. Haber DA, Timmers HT, Pelletier J, Sharp PA, Housman DE: A dominant mutation in the Wilms tumor gene WT1 cooperates with the viral oncogene E1A in transformation of primary kidney cells. Proc Natl Acad Sci USA 89:6010, 1992
45. Wang ZY, Qiu QQ, Gurrieri M, Huang J, Deuel TF: WT1, the Wilms' tumor suppressor gene product, represses transcription through an interactive nuclear protein. Oncogene 10:1243, 1995
46. Reddy JC, Morris JC, Wang J, English MA, Haber DA, Shi Y, Licht JD: WT1-mediated transcriptional activation is inhibited by dominant negative mutant proteins. J Biol Chem 270:10878, 1995
47. Maheswaran S, Park S, Bernard A, Morris JF, Rauscher Fd, Hill DE, Haber DA: Physical and functional interaction between WT1 and p53 proteins. Proc Natl Acad Sci USA 90:5100, 1993
48. Huff V, Jaffe N, Saunders GF, Strong LC, Villalba F, Ruteshouser EC: WT1 exon 1 deletion/insertion mutations in Wilms tumor patients, associated with di- and trinucleotide repeats and deletion hotspot consensus sequences. Am J Hum Genet 56:84, 1995
49. Wu Y, Fraizer GC, Saunders GF: GATA-1 transactivates the WT1 hematopoietic specific enhancer. J Biol Chem 270:5944, 1995
50. Phelan SA, Lindberg C, Call KM: Wilms' tumor gene, WT1, mRNA is down-regulated during induction of erythroid and megakaryocytic differentiation of K562 cells. Cell Growth Differ 5:677, 1994
51. Sekiya M, Adachi M, Hinoda Y, Imai K, Yachi A: Downregulation of Wilms' tumor gene (wt1) during myelomonocytic differentiation in HL60 cells. Blood 83:1876, 1994
52. Menssen HD, Renkl HJ, Rodeck U, Maurer J, Notter M, Schwartz S, Reinhardt R, Thiel E: Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. Leukemia 9:1060, 1995
53. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R: WT-1 is required for early kidney development. Cell 74:679, 1993